85. 特発性間質性肺炎 Idiopathic interstitial pneumonia Clinical trials / Disease details
臨床試験数 : 598 / 薬物数 : 435 - (DrugBank : 116) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 210
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04986540 (ClinicalTrials.gov) | August 30, 2021 | 27/7/2021 | A Trial of SHR - 1906 in Healthy Subjects | A Phase 1, Randomized, Double-Blind, Placebo-Controlled Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single IV Infusion of SHR-1906 in Healthy Subjects | Idiopathic Pulmonary Fibrosis | Drug: SHR-1906;Placebo | Guangdong Hengrui Pharmaceutical Co., Ltd | NULL | Not yet recruiting | 18 Years | 55 Years | All | 48 | Phase 1 | NULL |